DAs efficacy in reducing prolactin secretion resulting in normalized hormone levels in about 90% and inducing tumor shrinkage in 70–90% has positioned them as the cornerstone of medical treatment for prolactinoma patients [22]. Here, PRL is linked to neoplasm.